-
1.
公开(公告)号:US20130259883A1
公开(公告)日:2013-10-03
申请号:US13699563
申请日:2011-05-24
申请人: Donald F. Hunt , Jeffrey Shabanowitz , Jennifer Cottine , Ann M. English , Andrew Norris , Victor H. Engelhard , Mark Cobbold , Kara L. Cummings , Angela Zarling , Rebecca C. Obeng , Jie Qian
发明人: Donald F. Hunt , Jeffrey Shabanowitz , Jennifer Cottine , Ann M. English , Andrew Norris , Victor H. Engelhard , Mark Cobbold , Kara L. Cummings , Angela Zarling , Rebecca C. Obeng , Jie Qian
CPC分类号: C07K7/06 , A61K38/00 , A61K39/0011 , C07K7/08 , C07K14/70539 , C07K16/18 , G01N33/5743 , G01N33/57492 , G01N33/6893 , G01N2333/70539 , G01N2440/14
摘要: A set of phosphorylated peptides are presented by HLA A*0101, A*0201, A*0301, B*4402, B*2705, B*1402, and B*0702 on the surface of melanoma cells. They have the potential to (a) stimulate an immune response to the cancer, (b) to function as immunotherapeutics in adoptive T-cell therapy or as a vaccine, (c) to facilitate antibody recognition of the tumor boundaries in surgical pathology samples, and (d) act as biomarkers for early detection of the disease. Phosphorylated peptides are also presented for other cancers.
摘要翻译: 一组磷酸化肽由黑素瘤细胞表面上的HLA A * 0101,A * 0201,A * 0301,B * 4402,B * 2705,B * 1402和B * 0702呈现。 它们有可能(a)刺激对癌症的免疫应答,(b)在过继性T细胞治疗或疫苗中起到免疫治疗的作用,(c)促进外科病理样本中肿瘤边界的抗体识别, 和(d)作为早期检测疾病的生物标志物。 磷酸化肽也可用于其他癌症。
-
公开(公告)号:US20050277161A1
公开(公告)日:2005-12-15
申请号:US11146854
申请日:2005-06-07
申请人: Victor Engelhard , Angela Zarling , Donald Hunt , Anne Evans , Jeffrey Shabanowitz , Joy Polefrone , Leann Hopkins
发明人: Victor Engelhard , Angela Zarling , Donald Hunt , Anne Evans , Jeffrey Shabanowitz , Joy Polefrone , Leann Hopkins
IPC分类号: A61K39/00 , C07K14/47 , C07K14/82 , G01N33/00 , G01N33/574
CPC分类号: G01N33/574 , A61K39/00 , C07K14/4748 , G01N2333/70539
摘要: The present invention describes novel tumor-specific phosphorylated peptides, nucleic acids encoding those peptides, and antibodies generated against said peptides. The genes, peptides, and antibodies described herein may be used as diagnostic indicators of the presence of cancer and/or used in therapeutics to treat cancer.
摘要翻译: 本发明描述了新的肿瘤特异性磷酸化肽,编码这些肽的核酸和针对所述肽产生的抗体。 本文所述的基因,肽和抗体可用作癌症存在和/或用于治疗癌症的诊断指标。
-